Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Garcia

Showing results (221-230 of 1,188) with videos related to

Pageof 119
Sort By:
Journal of Clinical Microbiology|April 28, 2010
Breakthrough invasive candidiasis in patients on micafunginChristopher D Pfeiffer, Guillermo Garcia-Effron, Aimee K Zaas, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2008
Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandinsMaiken Cavling Arendrup, Susanne Perkhofer, Susan J Howard, et al.
Journal of Neuroscience Methods|March 21, 2015
Evaluation of optimal electrode configurations for epidural spinal cord stimulation in cervical spinal cord injured ratsMonzurul Alam, Guillermo Garcia-Alias, Prithvi K Shah, et al.
Blood|May 22, 2008
Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemiaConstantine S Tam, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Kidney International|January 25, 2025
Many strategies enabling us to optimize kidney care may also be planet friendlyGiorgina Barbara Piccoli, Guillermo Garcia-Garcia, Mario Salomone, et al.
Cancer|January 28, 2003
Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemiaGuillermo Garcia-Manero, Sima Jeha, Jerry Daniel, et al.
Leukemia & Lymphoma|August 6, 2016
Clinical use of ruxolitinib in an academic medical center in unselected patients with myeloproliferative neoplasms not on clinical studyKiran Naqvi, Naval Daver, Naveen Pemmaraju, et al.
Antimicrobial Agents and Chemotherapy|February 11, 2010
Novel FKS mutations associated with echinocandin resistance in Candida speciesGuillermo Garcia-Effron, Daniel Joseph Chua, Jon Rupert Tomada, et al.
Toxicology and Applied Pharmacology|January 13, 2018
Photo(geno)toxicity changes associated with hydroxylation of the aromatic chromophores during diclofenac metabolismGuillermo Garcia-Lainez, Ana M Martínez-Reig, Daniel Limones-Herrero, et al.
Blood|September 27, 2008
Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitorsElias Jabbour, Hagop M Kantarjian, Dan Jones, et al.
Pageof 119

Showing results (221-230 of 1,188) with videos related to

Sort By:
Pageof 119
Journal of Clinical Microbiology|April 28, 2010
Breakthrough invasive candidiasis in patients on micafunginChristopher D Pfeiffer, Guillermo Garcia-Effron, Aimee K Zaas, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2008
Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandinsMaiken Cavling Arendrup, Susanne Perkhofer, Susan J Howard, et al.
Journal of Neuroscience Methods|March 21, 2015
Evaluation of optimal electrode configurations for epidural spinal cord stimulation in cervical spinal cord injured ratsMonzurul Alam, Guillermo Garcia-Alias, Prithvi K Shah, et al.
Blood|May 22, 2008
Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemiaConstantine S Tam, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Kidney International|January 25, 2025
Many strategies enabling us to optimize kidney care may also be planet friendlyGiorgina Barbara Piccoli, Guillermo Garcia-Garcia, Mario Salomone, et al.
Cancer|January 28, 2003
Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemiaGuillermo Garcia-Manero, Sima Jeha, Jerry Daniel, et al.
Leukemia & Lymphoma|August 6, 2016
Clinical use of ruxolitinib in an academic medical center in unselected patients with myeloproliferative neoplasms not on clinical studyKiran Naqvi, Naval Daver, Naveen Pemmaraju, et al.
Antimicrobial Agents and Chemotherapy|February 11, 2010
Novel FKS mutations associated with echinocandin resistance in Candida speciesGuillermo Garcia-Effron, Daniel Joseph Chua, Jon Rupert Tomada, et al.
Toxicology and Applied Pharmacology|January 13, 2018
Photo(geno)toxicity changes associated with hydroxylation of the aromatic chromophores during diclofenac metabolismGuillermo Garcia-Lainez, Ana M Martínez-Reig, Daniel Limones-Herrero, et al.
Blood|September 27, 2008
Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitorsElias Jabbour, Hagop M Kantarjian, Dan Jones, et al.
Pageof 119